Robert Gut's Net Worth

$2.38 Million

Estimate Recalculated Sep 8, 2024 07:36PM EST

Who is Robert Gut?

Robert Gut has an estimated net worth of $2.38 Million. This is based on reported shares across multiple companies, which include uniQure N.V., and Versartis, Inc..

SEC CIK

Robert Gut's CIK is 0001716268

Past Insider Trading and Trends

2020 was Robert Gut's most active year for acquiring shares with 5 total transactions. Robert Gut's most active month to acquire stocks was the month of May. 2020 was Robert Gut's most active year for disposing of shares, totalling 6 transactions. Robert Gut's most active month to dispose stocks was the month of May. 2020 saw Robert Gut paying a total of $1,051,343.75 for 66,584 shares, this is the most they've acquired in one year. In 2020 Robert Gut cashed out on 65,595 shares for a total of $2,502,454.45, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

uniQure N.V. (QURE) Snapshot price: $5.42

Chief Medical Officer

Robert Gut owns 52,245 units of Ordinary Shares which is worth $283,167.90. From 2018 to 2024 Robert Gut acquired a total of 114,788 shares in uniQure N.V. at a cost of $1,051,343.75, Robert also disposed a total of 62,543 shares of uniQure N.V. equalling to $3,152,881.32.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+18.30%
8.08K
—
—
52.24K
Jun 19
Form 4
-7.35%
-3.50K
$5.12
-$17,940.48
44.16K
Jun 13
Form 4
+12.97%
5.47K
$18.88
-$60,944.64
47.67K
Jun 13 - Jun 16
Form 4
-4.46%
-1.97K
$20.79
-$40,907.19
42.2K
Feb 27 - Feb 28
Form 4
+25.88%
9.08K
—
—
44.16K
Jun 15
Form 4
-4.37%
-1.60K
$16.70
-$26,753.40
35.09K
Feb 28
Form 4
+4.36%
1.53K
—
—
36.69K
Feb 24
Form 4
-6.26%
-2.35K
$18.12
-$42,545.76
35.15K
Jan 26
Form 4
-10.71%
-4.50K
$36.61
-$164,745.00
37.5K
Sep 21
Form 4
-3.00%
-1.30K
$36.98
-$48,074.00
42K
Mar 2
Form 4
+5.82%
2.38K
—
—
43.3K
Feb 25
Form 4
-1.45%
-604.00
$39.09
-$23,610.36
40.92K
Jan 26
Form 4
-9.49%
-4.35K
$39.12
-$170,250.24
41.52K
Sep 21
Form 4
—
0
$54.56
-$829,906.25
45.88K
Scheduled
Jun 23
Form 4
+36.96%
12.38K
—
—
45.88K
Feb 27
Form 4
+20.12%
5.61K
—
—
33.49K
Jan 31
Form 4
-21.18%
-7.49K
$60.18
-$450,954.21
27.89K
Scheduled
Jan 27 - Jan 28
Form 4
-11.88%
-4.77K
$47.16
-$224,906.04
35.38K
Sep 19
Form 4
+14.71%
5.15K
—
—
40.15K
Jan 25
Form 4
∞
35K
—
—
35K
Sep 18
Form 4
—
0
—
—
0
Jun 14
Form 3
—
0
—
—
0
No matching records found

Versartis, Inc. (ARAV) No price found

Chief Medical Officer

Robert Gut owns 227,300 units of Common Stock. In the year 2017 Robert Gut filed a total of 4 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+67.13%
91.3K
—
—
227.3K
Dec 20
Form 4
+183.33%
88K
—
—
136K
Oct 6
Form 4
∞
48K
—
—
48K
Sep 5
Form 3
—
0
—
—
0
No matching records found